Global Gene Knockdown Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Gene Knockdown market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Gene Knockdown market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Gene Knockdown market size and forecasts, in consumption value ($ Million), 2020-2031
Global Gene Knockdown market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Gene Knockdown market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Gene Knockdown market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gene Knockdown
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gene Knockdown market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Santa Cruz Biotechnology (US), OriGene (US), Sigma-Aldrich (US), Abnova (Taiwan), Agilent Technologies (US), Bio-Rad (US), Cell Signaling Technology (US), GeneCopoeia (US), siTOOLs Biotech (Germany), Novus Biologicals (US), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Gene Knockdown market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Knockdown product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Knockdown, with revenue, gross margin, and global market share of Gene Knockdown from 2020 to 2025.
Chapter 3, the Gene Knockdown competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Gene Knockdown market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Knockdown.
Chapter 13, to describe Gene Knockdown research findings and conclusion.
This report is a detailed and comprehensive analysis for global Gene Knockdown market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Gene Knockdown market size and forecasts, in consumption value ($ Million), 2020-2031
Global Gene Knockdown market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Gene Knockdown market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Gene Knockdown market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gene Knockdown
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gene Knockdown market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Santa Cruz Biotechnology (US), OriGene (US), Sigma-Aldrich (US), Abnova (Taiwan), Agilent Technologies (US), Bio-Rad (US), Cell Signaling Technology (US), GeneCopoeia (US), siTOOLs Biotech (Germany), Novus Biologicals (US), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Gene Knockdown market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- siRNA
- shRNA
- Other
- Medical
- Bioengineering
- Other
- Santa Cruz Biotechnology (US)
- OriGene (US)
- Sigma-Aldrich (US)
- Abnova (Taiwan)
- Agilent Technologies (US)
- Bio-Rad (US)
- Cell Signaling Technology (US)
- GeneCopoeia (US)
- siTOOLs Biotech (Germany)
- Novus Biologicals (US)
- EMD Millipore (US)
- BioVision (US)
- Creative Biomart (US)
- Selleck Chemicals (US)
- MyBioSource (US)
- Invitrogen (US)
- Qiagen (Germany)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Knockdown product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Knockdown, with revenue, gross margin, and global market share of Gene Knockdown from 2020 to 2025.
Chapter 3, the Gene Knockdown competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Gene Knockdown market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Knockdown.
Chapter 13, to describe Gene Knockdown research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Gene Knockdown by Type
1.3.1 Overview: Global Gene Knockdown Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Gene Knockdown Consumption Value Market Share by Type in 2024
1.3.3 siRNA
1.3.4 shRNA
1.3.5 Other
1.4 Global Gene Knockdown Market by Application
1.4.1 Overview: Global Gene Knockdown Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Medical
1.4.3 Bioengineering
1.4.4 Other
1.5 Global Gene Knockdown Market Size & Forecast
1.6 Global Gene Knockdown Market Size and Forecast by Region
1.6.1 Global Gene Knockdown Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Gene Knockdown Market Size by Region, (2020-2031)
1.6.3 North America Gene Knockdown Market Size and Prospect (2020-2031)
1.6.4 Europe Gene Knockdown Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Gene Knockdown Market Size and Prospect (2020-2031)
1.6.6 South America Gene Knockdown Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Gene Knockdown Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Santa Cruz Biotechnology (US)
2.1.1 Santa Cruz Biotechnology (US) Details
2.1.2 Santa Cruz Biotechnology (US) Major Business
2.1.3 Santa Cruz Biotechnology (US) Gene Knockdown Product and Solutions
2.1.4 Santa Cruz Biotechnology (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Santa Cruz Biotechnology (US) Recent Developments and Future Plans
2.2 OriGene (US)
2.2.1 OriGene (US) Details
2.2.2 OriGene (US) Major Business
2.2.3 OriGene (US) Gene Knockdown Product and Solutions
2.2.4 OriGene (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 OriGene (US) Recent Developments and Future Plans
2.3 Sigma-Aldrich (US)
2.3.1 Sigma-Aldrich (US) Details
2.3.2 Sigma-Aldrich (US) Major Business
2.3.3 Sigma-Aldrich (US) Gene Knockdown Product and Solutions
2.3.4 Sigma-Aldrich (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Sigma-Aldrich (US) Recent Developments and Future Plans
2.4 Abnova (Taiwan)
2.4.1 Abnova (Taiwan) Details
2.4.2 Abnova (Taiwan) Major Business
2.4.3 Abnova (Taiwan) Gene Knockdown Product and Solutions
2.4.4 Abnova (Taiwan) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Abnova (Taiwan) Recent Developments and Future Plans
2.5 Agilent Technologies (US)
2.5.1 Agilent Technologies (US) Details
2.5.2 Agilent Technologies (US) Major Business
2.5.3 Agilent Technologies (US) Gene Knockdown Product and Solutions
2.5.4 Agilent Technologies (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Agilent Technologies (US) Recent Developments and Future Plans
2.6 Bio-Rad (US)
2.6.1 Bio-Rad (US) Details
2.6.2 Bio-Rad (US) Major Business
2.6.3 Bio-Rad (US) Gene Knockdown Product and Solutions
2.6.4 Bio-Rad (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Bio-Rad (US) Recent Developments and Future Plans
2.7 Cell Signaling Technology (US)
2.7.1 Cell Signaling Technology (US) Details
2.7.2 Cell Signaling Technology (US) Major Business
2.7.3 Cell Signaling Technology (US) Gene Knockdown Product and Solutions
2.7.4 Cell Signaling Technology (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Cell Signaling Technology (US) Recent Developments and Future Plans
2.8 GeneCopoeia (US)
2.8.1 GeneCopoeia (US) Details
2.8.2 GeneCopoeia (US) Major Business
2.8.3 GeneCopoeia (US) Gene Knockdown Product and Solutions
2.8.4 GeneCopoeia (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 GeneCopoeia (US) Recent Developments and Future Plans
2.9 siTOOLs Biotech (Germany)
2.9.1 siTOOLs Biotech (Germany) Details
2.9.2 siTOOLs Biotech (Germany) Major Business
2.9.3 siTOOLs Biotech (Germany) Gene Knockdown Product and Solutions
2.9.4 siTOOLs Biotech (Germany) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 siTOOLs Biotech (Germany) Recent Developments and Future Plans
2.10 Novus Biologicals (US)
2.10.1 Novus Biologicals (US) Details
2.10.2 Novus Biologicals (US) Major Business
2.10.3 Novus Biologicals (US) Gene Knockdown Product and Solutions
2.10.4 Novus Biologicals (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Novus Biologicals (US) Recent Developments and Future Plans
2.11 EMD Millipore (US)
2.11.1 EMD Millipore (US) Details
2.11.2 EMD Millipore (US) Major Business
2.11.3 EMD Millipore (US) Gene Knockdown Product and Solutions
2.11.4 EMD Millipore (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 EMD Millipore (US) Recent Developments and Future Plans
2.12 BioVision (US)
2.12.1 BioVision (US) Details
2.12.2 BioVision (US) Major Business
2.12.3 BioVision (US) Gene Knockdown Product and Solutions
2.12.4 BioVision (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 BioVision (US) Recent Developments and Future Plans
2.13 Creative Biomart (US)
2.13.1 Creative Biomart (US) Details
2.13.2 Creative Biomart (US) Major Business
2.13.3 Creative Biomart (US) Gene Knockdown Product and Solutions
2.13.4 Creative Biomart (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Creative Biomart (US) Recent Developments and Future Plans
2.14 Selleck Chemicals (US)
2.14.1 Selleck Chemicals (US) Details
2.14.2 Selleck Chemicals (US) Major Business
2.14.3 Selleck Chemicals (US) Gene Knockdown Product and Solutions
2.14.4 Selleck Chemicals (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Selleck Chemicals (US) Recent Developments and Future Plans
2.15 MyBioSource (US)
2.15.1 MyBioSource (US) Details
2.15.2 MyBioSource (US) Major Business
2.15.3 MyBioSource (US) Gene Knockdown Product and Solutions
2.15.4 MyBioSource (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 MyBioSource (US) Recent Developments and Future Plans
2.16 Invitrogen (US)
2.16.1 Invitrogen (US) Details
2.16.2 Invitrogen (US) Major Business
2.16.3 Invitrogen (US) Gene Knockdown Product and Solutions
2.16.4 Invitrogen (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Invitrogen (US) Recent Developments and Future Plans
2.17 Qiagen (Germany)
2.17.1 Qiagen (Germany) Details
2.17.2 Qiagen (Germany) Major Business
2.17.3 Qiagen (Germany) Gene Knockdown Product and Solutions
2.17.4 Qiagen (Germany) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Qiagen (Germany) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Gene Knockdown Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Gene Knockdown by Company Revenue
3.2.2 Top 3 Gene Knockdown Players Market Share in 2024
3.2.3 Top 6 Gene Knockdown Players Market Share in 2024
3.3 Gene Knockdown Market: Overall Company Footprint Analysis
3.3.1 Gene Knockdown Market: Region Footprint
3.3.2 Gene Knockdown Market: Company Product Type Footprint
3.3.3 Gene Knockdown Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Gene Knockdown Consumption Value and Market Share by Type (2020-2025)
4.2 Global Gene Knockdown Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Gene Knockdown Consumption Value Market Share by Application (2020-2025)
5.2 Global Gene Knockdown Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Gene Knockdown Consumption Value by Type (2020-2031)
6.2 North America Gene Knockdown Market Size by Application (2020-2031)
6.3 North America Gene Knockdown Market Size by Country
6.3.1 North America Gene Knockdown Consumption Value by Country (2020-2031)
6.3.2 United States Gene Knockdown Market Size and Forecast (2020-2031)
6.3.3 Canada Gene Knockdown Market Size and Forecast (2020-2031)
6.3.4 Mexico Gene Knockdown Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Gene Knockdown Consumption Value by Type (2020-2031)
7.2 Europe Gene Knockdown Consumption Value by Application (2020-2031)
7.3 Europe Gene Knockdown Market Size by Country
7.3.1 Europe Gene Knockdown Consumption Value by Country (2020-2031)
7.3.2 Germany Gene Knockdown Market Size and Forecast (2020-2031)
7.3.3 France Gene Knockdown Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Gene Knockdown Market Size and Forecast (2020-2031)
7.3.5 Russia Gene Knockdown Market Size and Forecast (2020-2031)
7.3.6 Italy Gene Knockdown Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Gene Knockdown Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Gene Knockdown Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Gene Knockdown Market Size by Region
8.3.1 Asia-Pacific Gene Knockdown Consumption Value by Region (2020-2031)
8.3.2 China Gene Knockdown Market Size and Forecast (2020-2031)
8.3.3 Japan Gene Knockdown Market Size and Forecast (2020-2031)
8.3.4 South Korea Gene Knockdown Market Size and Forecast (2020-2031)
8.3.5 India Gene Knockdown Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Gene Knockdown Market Size and Forecast (2020-2031)
8.3.7 Australia Gene Knockdown Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Gene Knockdown Consumption Value by Type (2020-2031)
9.2 South America Gene Knockdown Consumption Value by Application (2020-2031)
9.3 South America Gene Knockdown Market Size by Country
9.3.1 South America Gene Knockdown Consumption Value by Country (2020-2031)
9.3.2 Brazil Gene Knockdown Market Size and Forecast (2020-2031)
9.3.3 Argentina Gene Knockdown Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Gene Knockdown Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Gene Knockdown Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Gene Knockdown Market Size by Country
10.3.1 Middle East & Africa Gene Knockdown Consumption Value by Country (2020-2031)
10.3.2 Turkey Gene Knockdown Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Gene Knockdown Market Size and Forecast (2020-2031)
10.3.4 UAE Gene Knockdown Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Gene Knockdown Market Drivers
11.2 Gene Knockdown Market Restraints
11.3 Gene Knockdown Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Gene Knockdown Industry Chain
12.2 Gene Knockdown Upstream Analysis
12.3 Gene Knockdown Midstream Analysis
12.4 Gene Knockdown Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OFTABLES
Table 1. Global Gene Knockdown Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Gene Knockdown Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Gene Knockdown Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Gene Knockdown Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Santa Cruz Biotechnology (US) Company Information, Head Office, and Major Competitors
Table 6. Santa Cruz Biotechnology (US) Major Business
Table 7. Santa Cruz Biotechnology (US) Gene Knockdown Product and Solutions
Table 8. Santa Cruz Biotechnology (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Santa Cruz Biotechnology (US) Recent Developments andFuture Plans
Table 10. OriGene (US) Company Information, Head Office, and Major Competitors
Table 11. OriGene (US) Major Business
Table 12. OriGene (US) Gene Knockdown Product and Solutions
Table 13. OriGene (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. OriGene (US) Recent Developments andFuture Plans
Table 15. Sigma-Aldrich (US) Company Information, Head Office, and Major Competitors
Table 16. Sigma-Aldrich (US) Major Business
Table 17. Sigma-Aldrich (US) Gene Knockdown Product and Solutions
Table 18. Sigma-Aldrich (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Abnova (Taiwan) Company Information, Head Office, and Major Competitors
Table 20. Abnova (Taiwan) Major Business
Table 21. Abnova (Taiwan) Gene Knockdown Product and Solutions
Table 22. Abnova (Taiwan) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Abnova (Taiwan) Recent Developments andFuture Plans
Table 24. AgilentTechnologies (US) Company Information, Head Office, and Major Competitors
Table 25. AgilentTechnologies (US) Major Business
Table 26. AgilentTechnologies (US) Gene Knockdown Product and Solutions
Table 27. AgilentTechnologies (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. AgilentTechnologies (US) Recent Developments andFuture Plans
Table 29. Bio-Rad (US) Company Information, Head Office, and Major Competitors
Table 30. Bio-Rad (US) Major Business
Table 31. Bio-Rad (US) Gene Knockdown Product and Solutions
Table 32. Bio-Rad (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Bio-Rad (US) Recent Developments andFuture Plans
Table 34. Cell SignalingTechnology (US) Company Information, Head Office, and Major Competitors
Table 35. Cell SignalingTechnology (US) Major Business
Table 36. Cell SignalingTechnology (US) Gene Knockdown Product and Solutions
Table 37. Cell SignalingTechnology (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Cell SignalingTechnology (US) Recent Developments andFuture Plans
Table 39. GeneCopoeia (US) Company Information, Head Office, and Major Competitors
Table 40. GeneCopoeia (US) Major Business
Table 41. GeneCopoeia (US) Gene Knockdown Product and Solutions
Table 42. GeneCopoeia (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. GeneCopoeia (US) Recent Developments andFuture Plans
Table 44. siTOOLs Biotech (Germany) Company Information, Head Office, and Major Competitors
Table 45. siTOOLs Biotech (Germany) Major Business
Table 46. siTOOLs Biotech (Germany) Gene Knockdown Product and Solutions
Table 47. siTOOLs Biotech (Germany) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. siTOOLs Biotech (Germany) Recent Developments andFuture Plans
Table 49. Novus Biologicals (US) Company Information, Head Office, and Major Competitors
Table 50. Novus Biologicals (US) Major Business
Table 51. Novus Biologicals (US) Gene Knockdown Product and Solutions
Table 52. Novus Biologicals (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Novus Biologicals (US) Recent Developments andFuture Plans
Table 54. EMD Millipore (US) Company Information, Head Office, and Major Competitors
Table 55. EMD Millipore (US) Major Business
Table 56. EMD Millipore (US) Gene Knockdown Product and Solutions
Table 57. EMD Millipore (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. EMD Millipore (US) Recent Developments andFuture Plans
Table 59. BioVision (US) Company Information, Head Office, and Major Competitors
Table 60. BioVision (US) Major Business
Table 61. BioVision (US) Gene Knockdown Product and Solutions
Table 62. BioVision (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. BioVision (US) Recent Developments andFuture Plans
Table 64. Creative Biomart (US) Company Information, Head Office, and Major Competitors
Table 65. Creative Biomart (US) Major Business
Table 66. Creative Biomart (US) Gene Knockdown Product and Solutions
Table 67. Creative Biomart (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Creative Biomart (US) Recent Developments andFuture Plans
Table 69. Selleck Chemicals (US) Company Information, Head Office, and Major Competitors
Table 70. Selleck Chemicals (US) Major Business
Table 71. Selleck Chemicals (US) Gene Knockdown Product and Solutions
Table 72. Selleck Chemicals (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Selleck Chemicals (US) Recent Developments andFuture Plans
Table 74. MyBioSource (US) Company Information, Head Office, and Major Competitors
Table 75. MyBioSource (US) Major Business
Table 76. MyBioSource (US) Gene Knockdown Product and Solutions
Table 77. MyBioSource (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. MyBioSource (US) Recent Developments andFuture Plans
Table 79. Invitrogen (US) Company Information, Head Office, and Major Competitors
Table 80. Invitrogen (US) Major Business
Table 81. Invitrogen (US) Gene Knockdown Product and Solutions
Table 82. Invitrogen (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Invitrogen (US) Recent Developments andFuture Plans
Table 84. Qiagen (Germany) Company Information, Head Office, and Major Competitors
Table 85. Qiagen (Germany) Major Business
Table 86. Qiagen (Germany) Gene Knockdown Product and Solutions
Table 87. Qiagen (Germany) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. Qiagen (Germany) Recent Developments andFuture Plans
Table 89. Global Gene Knockdown Revenue (USD Million) by Players (2020-2025)
Table 90. Global Gene Knockdown Revenue Share by Players (2020-2025)
Table 91. Breakdown of Gene Knockdown by CompanyType (Tier 1,Tier 2, andTier 3)
Table 92. Market Position of Players in Gene Knockdown, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 93. Head Office of Key Gene Knockdown Players
Table 94. Gene Knockdown Market: Company ProductTypeFootprint
Table 95. Gene Knockdown Market: Company Product ApplicationFootprint
Table 96. Gene Knockdown New Market Entrants and Barriers to Market Entry
Table 97. Gene Knockdown Mergers, Acquisition, Agreements, and Collaborations
Table 98. Global Gene Knockdown Consumption Value (USD Million) byType (2020-2025)
Table 99. Global Gene Knockdown Consumption Value Share byType (2020-2025)
Table 100. Global Gene Knockdown Consumption ValueForecast byType (2026-2031)
Table 101. Global Gene Knockdown Consumption Value by Application (2020-2025)
Table 102. Global Gene Knockdown Consumption ValueForecast by Application (2026-2031)
Table 103. North America Gene Knockdown Consumption Value byType (2020-2025) & (USD Million)
Table 104. North America Gene Knockdown Consumption Value byType (2026-2031) & (USD Million)
Table 105. North America Gene Knockdown Consumption Value by Application (2020-2025) & (USD Million)
Table 106. North America Gene Knockdown Consumption Value by Application (2026-2031) & (USD Million)
Table 107. North America Gene Knockdown Consumption Value by Country (2020-2025) & (USD Million)
Table 108. North America Gene Knockdown Consumption Value by Country (2026-2031) & (USD Million)
Table 109. Europe Gene Knockdown Consumption Value byType (2020-2025) & (USD Million)
Table 110. Europe Gene Knockdown Consumption Value byType (2026-2031) & (USD Million)
Table 111. Europe Gene Knockdown Consumption Value by Application (2020-2025) & (USD Million)
Table 112. Europe Gene Knockdown Consumption Value by Application (2026-2031) & (USD Million)
Table 113. Europe Gene Knockdown Consumption Value by Country (2020-2025) & (USD Million)
Table 114. Europe Gene Knockdown Consumption Value by Country (2026-2031) & (USD Million)
Table 115. Asia-Pacific Gene Knockdown Consumption Value byType (2020-2025) & (USD Million)
Table 116. Asia-Pacific Gene Knockdown Consumption Value byType (2026-2031) & (USD Million)
Table 117. Asia-Pacific Gene Knockdown Consumption Value by Application (2020-2025) & (USD Million)
Table 118. Asia-Pacific Gene Knockdown Consumption Value by Application (2026-2031) & (USD Million)
Table 119. Asia-Pacific Gene Knockdown Consumption Value by Region (2020-2025) & (USD Million)
Table 120. Asia-Pacific Gene Knockdown Consumption Value by Region (2026-2031) & (USD Million)
Table 121. South America Gene Knockdown Consumption Value byType (2020-2025) & (USD Million)
Table 122. South America Gene Knockdown Consumption Value byType (2026-2031) & (USD Million)
Table 123. South America Gene Knockdown Consumption Value by Application (2020-2025) & (USD Million)
Table 124. South America Gene Knockdown Consumption Value by Application (2026-2031) & (USD Million)
Table 125. South America Gene Knockdown Consumption Value by Country (2020-2025) & (USD Million)
Table 126. South America Gene Knockdown Consumption Value by Country (2026-2031) & (USD Million)
Table 127. Middle East & Africa Gene Knockdown Consumption Value byType (2020-2025) & (USD Million)
Table 128. Middle East & Africa Gene Knockdown Consumption Value byType (2026-2031) & (USD Million)
Table 129. Middle East & Africa Gene Knockdown Consumption Value by Application (2020-2025) & (USD Million)
Table 130. Middle East & Africa Gene Knockdown Consumption Value by Application (2026-2031) & (USD Million)
Table 131. Middle East & Africa Gene Knockdown Consumption Value by Country (2020-2025) & (USD Million)
Table 132. Middle East & Africa Gene Knockdown Consumption Value by Country (2026-2031) & (USD Million)
Table 133. Global Key Players of Gene Knockdown Upstream (Raw Materials)
Table 134. Global Gene KnockdownTypical Customers
LIST OFFIGURES
Figure 1. Gene Knockdown Picture
Figure 2. Global Gene Knockdown Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Gene Knockdown Consumption Value Market Share byType in 2024
Figure 4. siRNA
Figure 5. shRNA
Figure 6. Other
Figure 7. Global Gene Knockdown Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Gene Knockdown Consumption Value Market Share by Application in 2024
Figure 9. Medical Picture
Figure 10. Bioengineering Picture
Figure 11. Other Picture
Figure 12. Global Gene Knockdown Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Gene Knockdown Consumption Value andForecast (2020-2031) & (USD Million)
Figure 14. Global Market Gene Knockdown Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 15. Global Gene Knockdown Consumption Value Market Share by Region (2020-2031)
Figure 16. Global Gene Knockdown Consumption Value Market Share by Region in 2024
Figure 17. North America Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 18. Europe Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 19. Asia-Pacific Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 20. South America Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 21. Middle East & Africa Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 22. CompanyThree Recent Developments andFuture Plans
Figure 23. Global Gene Knockdown Revenue Share by Players in 2024
Figure 24. Gene Knockdown Market Share by CompanyType (Tier 1,Tier 2, andTier 3) in 2024
Figure 25. Market Share of Gene Knockdown by Player Revenue in 2024
Figure 26.Top 3 Gene Knockdown Players Market Share in 2024
Figure 27.Top 6 Gene Knockdown Players Market Share in 2024
Figure 28. Global Gene Knockdown Consumption Value Share byType (2020-2025)
Figure 29. Global Gene Knockdown Market ShareForecast byType (2026-2031)
Figure 30. Global Gene Knockdown Consumption Value Share by Application (2020-2025)
Figure 31. Global Gene Knockdown Market ShareForecast by Application (2026-2031)
Figure 32. North America Gene Knockdown Consumption Value Market Share byType (2020-2031)
Figure 33. North America Gene Knockdown Consumption Value Market Share by Application (2020-2031)
Figure 34. North America Gene Knockdown Consumption Value Market Share by Country (2020-2031)
Figure 35. United States Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 36. Canada Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 37. Mexico Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 38. Europe Gene Knockdown Consumption Value Market Share byType (2020-2031)
Figure 39. Europe Gene Knockdown Consumption Value Market Share by Application (2020-2031)
Figure 40. Europe Gene Knockdown Consumption Value Market Share by Country (2020-2031)
Figure 41. Germany Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 42.France Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 43. United Kingdom Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 44. Russia Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 45. Italy Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 46. Asia-Pacific Gene Knockdown Consumption Value Market Share byType (2020-2031)
Figure 47. Asia-Pacific Gene Knockdown Consumption Value Market Share by Application (2020-2031)
Figure 48. Asia-Pacific Gene Knockdown Consumption Value Market Share by Region (2020-2031)
Figure 49. China Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 50. Japan Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 51. South Korea Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 52. India Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 53. Southeast Asia Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 54. Australia Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 55. South America Gene Knockdown Consumption Value Market Share byType (2020-2031)
Figure 56. South America Gene Knockdown Consumption Value Market Share by Application (2020-2031)
Figure 57. South America Gene Knockdown Consumption Value Market Share by Country (2020-2031)
Figure 58. Brazil Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 59. Argentina Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 60. Middle East & Africa Gene Knockdown Consumption Value Market Share byType (2020-2031)
Figure 61. Middle East & Africa Gene Knockdown Consumption Value Market Share by Application (2020-2031)
Figure 62. Middle East & Africa Gene Knockdown Consumption Value Market Share by Country (2020-2031)
Figure 63.Turkey Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 64. Saudi Arabia Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 65. UAE Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 66. Gene Knockdown Market Drivers
Figure 67. Gene Knockdown Market Restraints
Figure 68. Gene Knockdown MarketTrends
Figure 69. PortersFiveForces Analysis
Figure 70. Gene Knockdown Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Gene Knockdown by Type
1.3.1 Overview: Global Gene Knockdown Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Gene Knockdown Consumption Value Market Share by Type in 2024
1.3.3 siRNA
1.3.4 shRNA
1.3.5 Other
1.4 Global Gene Knockdown Market by Application
1.4.1 Overview: Global Gene Knockdown Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Medical
1.4.3 Bioengineering
1.4.4 Other
1.5 Global Gene Knockdown Market Size & Forecast
1.6 Global Gene Knockdown Market Size and Forecast by Region
1.6.1 Global Gene Knockdown Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Gene Knockdown Market Size by Region, (2020-2031)
1.6.3 North America Gene Knockdown Market Size and Prospect (2020-2031)
1.6.4 Europe Gene Knockdown Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Gene Knockdown Market Size and Prospect (2020-2031)
1.6.6 South America Gene Knockdown Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Gene Knockdown Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Santa Cruz Biotechnology (US)
2.1.1 Santa Cruz Biotechnology (US) Details
2.1.2 Santa Cruz Biotechnology (US) Major Business
2.1.3 Santa Cruz Biotechnology (US) Gene Knockdown Product and Solutions
2.1.4 Santa Cruz Biotechnology (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Santa Cruz Biotechnology (US) Recent Developments and Future Plans
2.2 OriGene (US)
2.2.1 OriGene (US) Details
2.2.2 OriGene (US) Major Business
2.2.3 OriGene (US) Gene Knockdown Product and Solutions
2.2.4 OriGene (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 OriGene (US) Recent Developments and Future Plans
2.3 Sigma-Aldrich (US)
2.3.1 Sigma-Aldrich (US) Details
2.3.2 Sigma-Aldrich (US) Major Business
2.3.3 Sigma-Aldrich (US) Gene Knockdown Product and Solutions
2.3.4 Sigma-Aldrich (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Sigma-Aldrich (US) Recent Developments and Future Plans
2.4 Abnova (Taiwan)
2.4.1 Abnova (Taiwan) Details
2.4.2 Abnova (Taiwan) Major Business
2.4.3 Abnova (Taiwan) Gene Knockdown Product and Solutions
2.4.4 Abnova (Taiwan) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Abnova (Taiwan) Recent Developments and Future Plans
2.5 Agilent Technologies (US)
2.5.1 Agilent Technologies (US) Details
2.5.2 Agilent Technologies (US) Major Business
2.5.3 Agilent Technologies (US) Gene Knockdown Product and Solutions
2.5.4 Agilent Technologies (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Agilent Technologies (US) Recent Developments and Future Plans
2.6 Bio-Rad (US)
2.6.1 Bio-Rad (US) Details
2.6.2 Bio-Rad (US) Major Business
2.6.3 Bio-Rad (US) Gene Knockdown Product and Solutions
2.6.4 Bio-Rad (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Bio-Rad (US) Recent Developments and Future Plans
2.7 Cell Signaling Technology (US)
2.7.1 Cell Signaling Technology (US) Details
2.7.2 Cell Signaling Technology (US) Major Business
2.7.3 Cell Signaling Technology (US) Gene Knockdown Product and Solutions
2.7.4 Cell Signaling Technology (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Cell Signaling Technology (US) Recent Developments and Future Plans
2.8 GeneCopoeia (US)
2.8.1 GeneCopoeia (US) Details
2.8.2 GeneCopoeia (US) Major Business
2.8.3 GeneCopoeia (US) Gene Knockdown Product and Solutions
2.8.4 GeneCopoeia (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 GeneCopoeia (US) Recent Developments and Future Plans
2.9 siTOOLs Biotech (Germany)
2.9.1 siTOOLs Biotech (Germany) Details
2.9.2 siTOOLs Biotech (Germany) Major Business
2.9.3 siTOOLs Biotech (Germany) Gene Knockdown Product and Solutions
2.9.4 siTOOLs Biotech (Germany) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 siTOOLs Biotech (Germany) Recent Developments and Future Plans
2.10 Novus Biologicals (US)
2.10.1 Novus Biologicals (US) Details
2.10.2 Novus Biologicals (US) Major Business
2.10.3 Novus Biologicals (US) Gene Knockdown Product and Solutions
2.10.4 Novus Biologicals (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Novus Biologicals (US) Recent Developments and Future Plans
2.11 EMD Millipore (US)
2.11.1 EMD Millipore (US) Details
2.11.2 EMD Millipore (US) Major Business
2.11.3 EMD Millipore (US) Gene Knockdown Product and Solutions
2.11.4 EMD Millipore (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 EMD Millipore (US) Recent Developments and Future Plans
2.12 BioVision (US)
2.12.1 BioVision (US) Details
2.12.2 BioVision (US) Major Business
2.12.3 BioVision (US) Gene Knockdown Product and Solutions
2.12.4 BioVision (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 BioVision (US) Recent Developments and Future Plans
2.13 Creative Biomart (US)
2.13.1 Creative Biomart (US) Details
2.13.2 Creative Biomart (US) Major Business
2.13.3 Creative Biomart (US) Gene Knockdown Product and Solutions
2.13.4 Creative Biomart (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Creative Biomart (US) Recent Developments and Future Plans
2.14 Selleck Chemicals (US)
2.14.1 Selleck Chemicals (US) Details
2.14.2 Selleck Chemicals (US) Major Business
2.14.3 Selleck Chemicals (US) Gene Knockdown Product and Solutions
2.14.4 Selleck Chemicals (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Selleck Chemicals (US) Recent Developments and Future Plans
2.15 MyBioSource (US)
2.15.1 MyBioSource (US) Details
2.15.2 MyBioSource (US) Major Business
2.15.3 MyBioSource (US) Gene Knockdown Product and Solutions
2.15.4 MyBioSource (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 MyBioSource (US) Recent Developments and Future Plans
2.16 Invitrogen (US)
2.16.1 Invitrogen (US) Details
2.16.2 Invitrogen (US) Major Business
2.16.3 Invitrogen (US) Gene Knockdown Product and Solutions
2.16.4 Invitrogen (US) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Invitrogen (US) Recent Developments and Future Plans
2.17 Qiagen (Germany)
2.17.1 Qiagen (Germany) Details
2.17.2 Qiagen (Germany) Major Business
2.17.3 Qiagen (Germany) Gene Knockdown Product and Solutions
2.17.4 Qiagen (Germany) Gene Knockdown Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Qiagen (Germany) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Gene Knockdown Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Gene Knockdown by Company Revenue
3.2.2 Top 3 Gene Knockdown Players Market Share in 2024
3.2.3 Top 6 Gene Knockdown Players Market Share in 2024
3.3 Gene Knockdown Market: Overall Company Footprint Analysis
3.3.1 Gene Knockdown Market: Region Footprint
3.3.2 Gene Knockdown Market: Company Product Type Footprint
3.3.3 Gene Knockdown Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Gene Knockdown Consumption Value and Market Share by Type (2020-2025)
4.2 Global Gene Knockdown Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Gene Knockdown Consumption Value Market Share by Application (2020-2025)
5.2 Global Gene Knockdown Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Gene Knockdown Consumption Value by Type (2020-2031)
6.2 North America Gene Knockdown Market Size by Application (2020-2031)
6.3 North America Gene Knockdown Market Size by Country
6.3.1 North America Gene Knockdown Consumption Value by Country (2020-2031)
6.3.2 United States Gene Knockdown Market Size and Forecast (2020-2031)
6.3.3 Canada Gene Knockdown Market Size and Forecast (2020-2031)
6.3.4 Mexico Gene Knockdown Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Gene Knockdown Consumption Value by Type (2020-2031)
7.2 Europe Gene Knockdown Consumption Value by Application (2020-2031)
7.3 Europe Gene Knockdown Market Size by Country
7.3.1 Europe Gene Knockdown Consumption Value by Country (2020-2031)
7.3.2 Germany Gene Knockdown Market Size and Forecast (2020-2031)
7.3.3 France Gene Knockdown Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Gene Knockdown Market Size and Forecast (2020-2031)
7.3.5 Russia Gene Knockdown Market Size and Forecast (2020-2031)
7.3.6 Italy Gene Knockdown Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Gene Knockdown Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Gene Knockdown Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Gene Knockdown Market Size by Region
8.3.1 Asia-Pacific Gene Knockdown Consumption Value by Region (2020-2031)
8.3.2 China Gene Knockdown Market Size and Forecast (2020-2031)
8.3.3 Japan Gene Knockdown Market Size and Forecast (2020-2031)
8.3.4 South Korea Gene Knockdown Market Size and Forecast (2020-2031)
8.3.5 India Gene Knockdown Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Gene Knockdown Market Size and Forecast (2020-2031)
8.3.7 Australia Gene Knockdown Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Gene Knockdown Consumption Value by Type (2020-2031)
9.2 South America Gene Knockdown Consumption Value by Application (2020-2031)
9.3 South America Gene Knockdown Market Size by Country
9.3.1 South America Gene Knockdown Consumption Value by Country (2020-2031)
9.3.2 Brazil Gene Knockdown Market Size and Forecast (2020-2031)
9.3.3 Argentina Gene Knockdown Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Gene Knockdown Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Gene Knockdown Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Gene Knockdown Market Size by Country
10.3.1 Middle East & Africa Gene Knockdown Consumption Value by Country (2020-2031)
10.3.2 Turkey Gene Knockdown Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Gene Knockdown Market Size and Forecast (2020-2031)
10.3.4 UAE Gene Knockdown Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Gene Knockdown Market Drivers
11.2 Gene Knockdown Market Restraints
11.3 Gene Knockdown Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Gene Knockdown Industry Chain
12.2 Gene Knockdown Upstream Analysis
12.3 Gene Knockdown Midstream Analysis
12.4 Gene Knockdown Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OFTABLES
Table 1. Global Gene Knockdown Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Gene Knockdown Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Gene Knockdown Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Gene Knockdown Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Santa Cruz Biotechnology (US) Company Information, Head Office, and Major Competitors
Table 6. Santa Cruz Biotechnology (US) Major Business
Table 7. Santa Cruz Biotechnology (US) Gene Knockdown Product and Solutions
Table 8. Santa Cruz Biotechnology (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Santa Cruz Biotechnology (US) Recent Developments andFuture Plans
Table 10. OriGene (US) Company Information, Head Office, and Major Competitors
Table 11. OriGene (US) Major Business
Table 12. OriGene (US) Gene Knockdown Product and Solutions
Table 13. OriGene (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. OriGene (US) Recent Developments andFuture Plans
Table 15. Sigma-Aldrich (US) Company Information, Head Office, and Major Competitors
Table 16. Sigma-Aldrich (US) Major Business
Table 17. Sigma-Aldrich (US) Gene Knockdown Product and Solutions
Table 18. Sigma-Aldrich (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Abnova (Taiwan) Company Information, Head Office, and Major Competitors
Table 20. Abnova (Taiwan) Major Business
Table 21. Abnova (Taiwan) Gene Knockdown Product and Solutions
Table 22. Abnova (Taiwan) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Abnova (Taiwan) Recent Developments andFuture Plans
Table 24. AgilentTechnologies (US) Company Information, Head Office, and Major Competitors
Table 25. AgilentTechnologies (US) Major Business
Table 26. AgilentTechnologies (US) Gene Knockdown Product and Solutions
Table 27. AgilentTechnologies (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. AgilentTechnologies (US) Recent Developments andFuture Plans
Table 29. Bio-Rad (US) Company Information, Head Office, and Major Competitors
Table 30. Bio-Rad (US) Major Business
Table 31. Bio-Rad (US) Gene Knockdown Product and Solutions
Table 32. Bio-Rad (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Bio-Rad (US) Recent Developments andFuture Plans
Table 34. Cell SignalingTechnology (US) Company Information, Head Office, and Major Competitors
Table 35. Cell SignalingTechnology (US) Major Business
Table 36. Cell SignalingTechnology (US) Gene Knockdown Product and Solutions
Table 37. Cell SignalingTechnology (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Cell SignalingTechnology (US) Recent Developments andFuture Plans
Table 39. GeneCopoeia (US) Company Information, Head Office, and Major Competitors
Table 40. GeneCopoeia (US) Major Business
Table 41. GeneCopoeia (US) Gene Knockdown Product and Solutions
Table 42. GeneCopoeia (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. GeneCopoeia (US) Recent Developments andFuture Plans
Table 44. siTOOLs Biotech (Germany) Company Information, Head Office, and Major Competitors
Table 45. siTOOLs Biotech (Germany) Major Business
Table 46. siTOOLs Biotech (Germany) Gene Knockdown Product and Solutions
Table 47. siTOOLs Biotech (Germany) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. siTOOLs Biotech (Germany) Recent Developments andFuture Plans
Table 49. Novus Biologicals (US) Company Information, Head Office, and Major Competitors
Table 50. Novus Biologicals (US) Major Business
Table 51. Novus Biologicals (US) Gene Knockdown Product and Solutions
Table 52. Novus Biologicals (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Novus Biologicals (US) Recent Developments andFuture Plans
Table 54. EMD Millipore (US) Company Information, Head Office, and Major Competitors
Table 55. EMD Millipore (US) Major Business
Table 56. EMD Millipore (US) Gene Knockdown Product and Solutions
Table 57. EMD Millipore (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. EMD Millipore (US) Recent Developments andFuture Plans
Table 59. BioVision (US) Company Information, Head Office, and Major Competitors
Table 60. BioVision (US) Major Business
Table 61. BioVision (US) Gene Knockdown Product and Solutions
Table 62. BioVision (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. BioVision (US) Recent Developments andFuture Plans
Table 64. Creative Biomart (US) Company Information, Head Office, and Major Competitors
Table 65. Creative Biomart (US) Major Business
Table 66. Creative Biomart (US) Gene Knockdown Product and Solutions
Table 67. Creative Biomart (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Creative Biomart (US) Recent Developments andFuture Plans
Table 69. Selleck Chemicals (US) Company Information, Head Office, and Major Competitors
Table 70. Selleck Chemicals (US) Major Business
Table 71. Selleck Chemicals (US) Gene Knockdown Product and Solutions
Table 72. Selleck Chemicals (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Selleck Chemicals (US) Recent Developments andFuture Plans
Table 74. MyBioSource (US) Company Information, Head Office, and Major Competitors
Table 75. MyBioSource (US) Major Business
Table 76. MyBioSource (US) Gene Knockdown Product and Solutions
Table 77. MyBioSource (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. MyBioSource (US) Recent Developments andFuture Plans
Table 79. Invitrogen (US) Company Information, Head Office, and Major Competitors
Table 80. Invitrogen (US) Major Business
Table 81. Invitrogen (US) Gene Knockdown Product and Solutions
Table 82. Invitrogen (US) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Invitrogen (US) Recent Developments andFuture Plans
Table 84. Qiagen (Germany) Company Information, Head Office, and Major Competitors
Table 85. Qiagen (Germany) Major Business
Table 86. Qiagen (Germany) Gene Knockdown Product and Solutions
Table 87. Qiagen (Germany) Gene Knockdown Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. Qiagen (Germany) Recent Developments andFuture Plans
Table 89. Global Gene Knockdown Revenue (USD Million) by Players (2020-2025)
Table 90. Global Gene Knockdown Revenue Share by Players (2020-2025)
Table 91. Breakdown of Gene Knockdown by CompanyType (Tier 1,Tier 2, andTier 3)
Table 92. Market Position of Players in Gene Knockdown, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 93. Head Office of Key Gene Knockdown Players
Table 94. Gene Knockdown Market: Company ProductTypeFootprint
Table 95. Gene Knockdown Market: Company Product ApplicationFootprint
Table 96. Gene Knockdown New Market Entrants and Barriers to Market Entry
Table 97. Gene Knockdown Mergers, Acquisition, Agreements, and Collaborations
Table 98. Global Gene Knockdown Consumption Value (USD Million) byType (2020-2025)
Table 99. Global Gene Knockdown Consumption Value Share byType (2020-2025)
Table 100. Global Gene Knockdown Consumption ValueForecast byType (2026-2031)
Table 101. Global Gene Knockdown Consumption Value by Application (2020-2025)
Table 102. Global Gene Knockdown Consumption ValueForecast by Application (2026-2031)
Table 103. North America Gene Knockdown Consumption Value byType (2020-2025) & (USD Million)
Table 104. North America Gene Knockdown Consumption Value byType (2026-2031) & (USD Million)
Table 105. North America Gene Knockdown Consumption Value by Application (2020-2025) & (USD Million)
Table 106. North America Gene Knockdown Consumption Value by Application (2026-2031) & (USD Million)
Table 107. North America Gene Knockdown Consumption Value by Country (2020-2025) & (USD Million)
Table 108. North America Gene Knockdown Consumption Value by Country (2026-2031) & (USD Million)
Table 109. Europe Gene Knockdown Consumption Value byType (2020-2025) & (USD Million)
Table 110. Europe Gene Knockdown Consumption Value byType (2026-2031) & (USD Million)
Table 111. Europe Gene Knockdown Consumption Value by Application (2020-2025) & (USD Million)
Table 112. Europe Gene Knockdown Consumption Value by Application (2026-2031) & (USD Million)
Table 113. Europe Gene Knockdown Consumption Value by Country (2020-2025) & (USD Million)
Table 114. Europe Gene Knockdown Consumption Value by Country (2026-2031) & (USD Million)
Table 115. Asia-Pacific Gene Knockdown Consumption Value byType (2020-2025) & (USD Million)
Table 116. Asia-Pacific Gene Knockdown Consumption Value byType (2026-2031) & (USD Million)
Table 117. Asia-Pacific Gene Knockdown Consumption Value by Application (2020-2025) & (USD Million)
Table 118. Asia-Pacific Gene Knockdown Consumption Value by Application (2026-2031) & (USD Million)
Table 119. Asia-Pacific Gene Knockdown Consumption Value by Region (2020-2025) & (USD Million)
Table 120. Asia-Pacific Gene Knockdown Consumption Value by Region (2026-2031) & (USD Million)
Table 121. South America Gene Knockdown Consumption Value byType (2020-2025) & (USD Million)
Table 122. South America Gene Knockdown Consumption Value byType (2026-2031) & (USD Million)
Table 123. South America Gene Knockdown Consumption Value by Application (2020-2025) & (USD Million)
Table 124. South America Gene Knockdown Consumption Value by Application (2026-2031) & (USD Million)
Table 125. South America Gene Knockdown Consumption Value by Country (2020-2025) & (USD Million)
Table 126. South America Gene Knockdown Consumption Value by Country (2026-2031) & (USD Million)
Table 127. Middle East & Africa Gene Knockdown Consumption Value byType (2020-2025) & (USD Million)
Table 128. Middle East & Africa Gene Knockdown Consumption Value byType (2026-2031) & (USD Million)
Table 129. Middle East & Africa Gene Knockdown Consumption Value by Application (2020-2025) & (USD Million)
Table 130. Middle East & Africa Gene Knockdown Consumption Value by Application (2026-2031) & (USD Million)
Table 131. Middle East & Africa Gene Knockdown Consumption Value by Country (2020-2025) & (USD Million)
Table 132. Middle East & Africa Gene Knockdown Consumption Value by Country (2026-2031) & (USD Million)
Table 133. Global Key Players of Gene Knockdown Upstream (Raw Materials)
Table 134. Global Gene KnockdownTypical Customers
LIST OFFIGURES
Figure 1. Gene Knockdown Picture
Figure 2. Global Gene Knockdown Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Gene Knockdown Consumption Value Market Share byType in 2024
Figure 4. siRNA
Figure 5. shRNA
Figure 6. Other
Figure 7. Global Gene Knockdown Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Gene Knockdown Consumption Value Market Share by Application in 2024
Figure 9. Medical Picture
Figure 10. Bioengineering Picture
Figure 11. Other Picture
Figure 12. Global Gene Knockdown Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Gene Knockdown Consumption Value andForecast (2020-2031) & (USD Million)
Figure 14. Global Market Gene Knockdown Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 15. Global Gene Knockdown Consumption Value Market Share by Region (2020-2031)
Figure 16. Global Gene Knockdown Consumption Value Market Share by Region in 2024
Figure 17. North America Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 18. Europe Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 19. Asia-Pacific Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 20. South America Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 21. Middle East & Africa Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 22. CompanyThree Recent Developments andFuture Plans
Figure 23. Global Gene Knockdown Revenue Share by Players in 2024
Figure 24. Gene Knockdown Market Share by CompanyType (Tier 1,Tier 2, andTier 3) in 2024
Figure 25. Market Share of Gene Knockdown by Player Revenue in 2024
Figure 26.Top 3 Gene Knockdown Players Market Share in 2024
Figure 27.Top 6 Gene Knockdown Players Market Share in 2024
Figure 28. Global Gene Knockdown Consumption Value Share byType (2020-2025)
Figure 29. Global Gene Knockdown Market ShareForecast byType (2026-2031)
Figure 30. Global Gene Knockdown Consumption Value Share by Application (2020-2025)
Figure 31. Global Gene Knockdown Market ShareForecast by Application (2026-2031)
Figure 32. North America Gene Knockdown Consumption Value Market Share byType (2020-2031)
Figure 33. North America Gene Knockdown Consumption Value Market Share by Application (2020-2031)
Figure 34. North America Gene Knockdown Consumption Value Market Share by Country (2020-2031)
Figure 35. United States Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 36. Canada Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 37. Mexico Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 38. Europe Gene Knockdown Consumption Value Market Share byType (2020-2031)
Figure 39. Europe Gene Knockdown Consumption Value Market Share by Application (2020-2031)
Figure 40. Europe Gene Knockdown Consumption Value Market Share by Country (2020-2031)
Figure 41. Germany Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 42.France Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 43. United Kingdom Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 44. Russia Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 45. Italy Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 46. Asia-Pacific Gene Knockdown Consumption Value Market Share byType (2020-2031)
Figure 47. Asia-Pacific Gene Knockdown Consumption Value Market Share by Application (2020-2031)
Figure 48. Asia-Pacific Gene Knockdown Consumption Value Market Share by Region (2020-2031)
Figure 49. China Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 50. Japan Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 51. South Korea Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 52. India Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 53. Southeast Asia Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 54. Australia Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 55. South America Gene Knockdown Consumption Value Market Share byType (2020-2031)
Figure 56. South America Gene Knockdown Consumption Value Market Share by Application (2020-2031)
Figure 57. South America Gene Knockdown Consumption Value Market Share by Country (2020-2031)
Figure 58. Brazil Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 59. Argentina Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 60. Middle East & Africa Gene Knockdown Consumption Value Market Share byType (2020-2031)
Figure 61. Middle East & Africa Gene Knockdown Consumption Value Market Share by Application (2020-2031)
Figure 62. Middle East & Africa Gene Knockdown Consumption Value Market Share by Country (2020-2031)
Figure 63.Turkey Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 64. Saudi Arabia Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 65. UAE Gene Knockdown Consumption Value (2020-2031) & (USD Million)
Figure 66. Gene Knockdown Market Drivers
Figure 67. Gene Knockdown Market Restraints
Figure 68. Gene Knockdown MarketTrends
Figure 69. PortersFiveForces Analysis
Figure 70. Gene Knockdown Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
More Publications
Global Gene Synthesis Market 2025 by Company, Regions, Type and Application, Forecast to 2031
US$ 3,480.00
February 2025
116 pages
Global Hemophilia Gene Therapy Market 2025 by Company, Regions, Type and Application, Forecast to 2031
US$ 3,480.00
January 2025
93 pages
Global Gene Therapy Market 2026 by Company, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
January 2026
125 pages
